There is no single milligram dose of lithium that reliably kills a person, which is exactly what makes lithium one of the trickiest drugs in all of medicine. Fatalities have occurred at surprisingly modest doses in people with impaired kidneys, while others have survived massive intentional overdoses. What determines whether lithium exposure is survivable has far more to do with your serum concentration over time, your kidney function, and what other medications you take than with the raw number of milligrams swallowed. The gap between a therapeutic dose and a dangerous one is razor-thin, and understanding that gap matters far more than memorizing a single number.
Why No Single Milligram Threshold Exists
Lithium carbonate, the form most commonly prescribed for bipolar disorder, is typically dosed at 900 to 1,800 mg per day in adults. That range already tells you something: a dose that stabilizes one person’s mood could overwhelm another person’s kidneys. The therapeutic blood level sits between about 0.6 and 1.2 mmol/L, and concentrations above 1.2 mmol/L are considered potentially toxic and can be fatal.1PubMed Central. Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder That is an extraordinarily narrow window for any medication. A person whose kidneys clear lithium efficiently might tolerate 1,500 mg a day without difficulty. A person who is dehydrated, elderly, or taking certain common medications might reach toxic serum levels on a dose well below that.
Published case reports of fatal lithium poisoning tend to describe serum concentrations rather than ingested milligrams, because clinicians have learned that the number of pills swallowed is a poor predictor of what happens next. One fatal case in the literature documented a blood lithium level of 3.79 mmol/L, more than three times the upper therapeutic limit, alongside kidney failure.2PubMed. A rare case of fatal poisoning during long-term therapy with lithium carbonate – chronic poisoning, suicide or psychiatric malpractice? But deaths have also been reported at lower serum levels when exposure was prolonged and the brain had time to accumulate lithium. The milligram dose that produced those levels varied enormously from case to case.
Three Distinct Patterns of Toxicity
One reason the fatal-dose question resists a simple answer is that lithium poisoning comes in three different forms, each with its own risk profile. Acute toxicity occurs in someone who does not regularly take lithium and swallows a large amount at once. Acute-on-chronic toxicity is an overdose in someone already on lithium therapy. Chronic toxicity is a gradual buildup in someone taking their prescribed dose, often triggered by a change in kidney function or a new medication.3The Primary Care Companion for CNS Disorders. A Tale of 2 Lithium Toxicities
Counterintuitively, the chronic and acute-on-chronic patterns tend to be more dangerous than a one-time large ingestion. Lithium distributes slowly into the brain, so someone who has been accumulating it for days or weeks may already have high concentrations in their central nervous system by the time anyone notices something is wrong. In contrast, someone who swallows a large single dose may have a sky-high blood level but relatively lower brain exposure in the first hours, buying time for treatment. The duration of exposure to elevated levels correlates with the severity of brain damage more reliably than the peak blood level does.3The Primary Care Companion for CNS Disorders. A Tale of 2 Lithium Toxicities This means the absolute serum level can be misleading. A blood reading of 2.5 mmol/L in a chronic user can represent a far more dangerous situation than the same reading in someone who just swallowed a handful of pills an hour ago.
Serum Levels That Signal Danger
While the relationship between blood levels and symptoms is imperfect, clinical guidelines and forensic data do offer useful benchmarks. Levels above 1.5 mmol/L are generally considered toxic. Above 2.5 mmol/L, life-threatening complications become increasingly likely. Levels above 4.0 mmol/L in the setting of impaired kidneys, or above 5.0 mmol/L regardless of kidney function, meet criteria for emergency extracorporeal treatment like hemodialysis.4PubMed Central. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup
Forensic studies shed light on what levels are actually found in people who die. A study of postmortem blood lithium concentrations found that people who died from lithium-related causes had a median femoral blood level of about 2.7 mmol/L, significantly higher than a control group with a median of 0.2 mmol/L.5Forensic Science International. Reference values of lithium in postmortem femoral blood An Australian review of lithium-related deaths from 2000 to 2024 found that intentional overdose cases had a median blood lithium level of 2.2 mmol/L, compared to 0.5 mmol/L in unintentional cases.6Australian & New Zealand Journal of Psychiatry. Characteristics of deaths related to lithium toxicity in Australia, 2000-2024 That difference highlights that unintentional deaths, often from chronic accumulation, can occur at blood levels that might not immediately alarm a clinician looking only at a single lab result.
A critical wrinkle: toxic symptoms can appear even when blood concentrations fall within the so-called therapeutic range.7PubMed Central. Lithium Intoxication Accompanied by Hyponatremia This is especially true when low sodium levels or kidney problems are present, because these conditions alter how lithium distributes through the body and brain.
Medications and Conditions That Tip the Balance
Lithium is cleared from the body almost entirely by the kidneys. Any medication or condition that changes how the kidneys handle sodium and water can push lithium levels upward, sometimes dangerously. Three classes of commonly prescribed drugs are the most frequent culprits:
- Thiazide diuretics: These water pills, often prescribed for high blood pressure, have the greatest potential to raise lithium levels, with increases of 25 to 40% commonly seen after starting therapy.
- NSAIDs: Over-the-counter painkillers like ibuprofen and naproxen can impair lithium elimination, though the degree of interaction varies between specific drugs.
- ACE inhibitors: Blood pressure medications in this class may also reduce the kidneys’ ability to clear lithium.
These interactions are well documented and clinically significant.8PubMed. Clinical relevance of drug interactions with lithium Angiotensin receptor blockers, a related class of blood pressure medications, carry a similar risk.9PubMed Central. Lithium therapy and its interactions The practical danger here is that many of these drugs are prescribed casually by doctors who may not realize their patient is on lithium, or that patients may buy NSAIDs over the counter without thinking twice about it. A person who has been stable on lithium for years can slide into toxicity after starting ibuprofen for knee pain.
Dehydration is another major trigger. Anything that causes significant fluid loss, including vomiting, diarrhea, heavy sweating, or a fever, concentrates lithium in the blood. Hyponatremia, or low sodium, compounds the problem because lithium and sodium compete for reabsorption in the kidney tubules. When sodium is scarce, the kidneys hold on to more lithium instead.
How Lithium Harms the Brain and Heart
The brain is the organ most vulnerable to lithium toxicity. Early symptoms include tremor, nausea, and diarrhea. As levels rise, confusion, slurred speech, and unsteadiness appear. At severe levels, the picture can progress to seizures, coma, and death.10PubMed. Lithium Poisoning The progression from mild to life-threatening can be deceptively slow in chronic cases, because gastrointestinal symptoms that serve as early warnings in acute poisoning may be absent when toxicity develops gradually.
The heart is the other major target. Lithium can cause a range of electrical disturbances in the heart, from benign-looking T-wave changes on an electrocardiogram all the way to dangerous rhythm problems. T-wave inversion is the most commonly reported finding, but sinus node dysfunction, heart blocks, QT prolongation, and even ventricular arrhythmias have all been documented.11PubMed Central. Lithium-induced electrocardiographic changes: A complete review Some patients have developed patterns on their heart tracings that mimic a heart attack or Brugada syndrome, a condition associated with sudden cardiac death. In one case, an elderly patient with lithium intoxication showed sinus bradycardia, rapid atrial fibrillation, and second-degree heart block all in the same episode.12PubMed Central. Electrocardiographic changes caused by lithium intoxication in an elderly patient
The kidneys also suffer. Lithium can impair the collecting ducts’ ability to respond to antidiuretic hormone, leading to a condition called nephrogenic diabetes insipidus, where the kidneys produce enormous volumes of dilute urine.13PubMed Central. Reversible Nephrogenic Diabetes Insipidus Induced by Lithium: A Case Report This creates a vicious cycle in acute toxicity: the kidneys are already struggling to clear lithium, and the resulting fluid loss through excessive urination makes dehydration worse, which further impairs clearance.
Emergency Treatment and When Dialysis Is Needed
Standard overdose treatments like activated charcoal are not effective against lithium, because lithium is a simple ion that charcoal does not bind well. The mainstay of treatment is aggressive intravenous fluids to support kidney function and, in severe cases, hemodialysis to physically remove lithium from the blood.
The EXTRIP workgroup, an international collaboration of toxicologists and nephrologists, has published the most comprehensive guidelines on when to dialyze. They recommend hemodialysis when kidney function is impaired and the lithium level exceeds 4.0 mmol/L, or when a patient has a decreased level of consciousness, seizures, or life-threatening heart rhythm disturbances regardless of what the level reads. They also suggest considering dialysis when the lithium level is above 5.0 mmol/L, when significant confusion is present, or when it would take more than 36 hours for the body to bring the level below 1.0 mmol/L on its own.4PubMed Central. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup
In practice, applying these criteria is not straightforward. A review evaluating how the EXTRIP guidelines would have applied to real cases found that following them strictly would have triggered dialysis in about 58% of patients. But among those with chronic toxicity, only a fraction met both a concentration criterion and a clinical criterion simultaneously, suggesting that the guidelines may be better calibrated for acute overdoses than for the slower chronic pattern.14PubMed Central. Haemodialysis for lithium poisoning: Translating EXTRIP recommendations into practical guidelines Timing matters enormously. In that same analysis, late neurological damage was observed in nearly all patients who met both a concentration and a clinical criterion on admission.
When the Damage Does Not Reverse
Most people who survive lithium toxicity recover fully, but a troubling minority do not. Even after lithium is cleared from the blood and levels return to normal, some patients are left with permanent neurological deficits. This has been given its own clinical name: the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity, known by the apt acronym SILENT.15European Psychiatry. Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): A Review
A scoping review of SILENT cases found that persistent cerebellar dysfunction was the most common outcome, appearing in about 77% of cases. Symptoms included difficulty with coordination and balance, cognitive problems, movement disorders resembling Parkinson’s disease, and peripheral nerve damage. These deficits can last weeks, months, or years, and in some cases they are lifelong.16PubMed Central. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity: A Scoping Review SILENT can develop even after timely hemodialysis that successfully normalizes serum lithium levels.17International Journal of Drug Delivery Technology. When Silence Persists: Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT) Following Acute Lithium Overdose The mechanism is thought to involve lithium’s slow accumulation in brain tissue, meaning that by the time blood levels are corrected, the damage to neurons has already been done.
This is arguably the most underappreciated aspect of lithium toxicity. Survival is not the only benchmark. A person who is rescued from a fatal lithium level but left with permanent cerebellar damage, unable to walk steadily or think clearly, has experienced a devastating outcome even though they lived.
Children and Accidental Ingestions
Pediatric lithium exposures are overwhelmingly accidental, typically involving a toddler who finds a parent’s or grandparent’s medication. A large study of acute exploratory pediatric lithium ingestions found that the vast majority resulted in no clinical effect or only minor symptoms. Among the roughly 10% of children who developed any symptoms, the most common were vomiting and drowsiness. No deaths were reported, and no cases resulted in symptoms thought to be permanent.18PubMed. Outcomes of acute exploratory pediatric lithium ingestions In most cases where symptoms appeared, they resolved within eight hours.
The relatively reassuring pediatric data reflects the nature of exploratory ingestions: a child typically swallows one or a few tablets, not a large quantity. This is a fundamentally different scenario from an intentional adult overdose. It does not mean lithium is safe for children in larger amounts, and any suspected ingestion still warrants urgent medical evaluation because the therapeutic window is even narrower in smaller bodies with immature kidneys.
Newborns present a separate concern. Lithium crosses the placenta, and infants born to mothers taking lithium can have elevated serum levels at birth. One study found that when maternal lithium levels were high at delivery, roughly 86% of newborns showed symptoms. Even in the lower-exposure group, about 41% had some neonatal effects.19SpringerOpen / International Journal of Bipolar Disorders. High lithium concentration at delivery is a potential risk factor for adverse outcomes in breastfed infants: a retrospective cohort study Higher-exposure infants were also more likely to require neonatal intensive care.
Over-the-Counter Lithium Supplements
Lithium is available without a prescription in supplement form, typically as lithium orotate or lithium aspartate. The doses involved are orders of magnitude smaller than prescription lithium carbonate. A survey of supplement users found that the most common dose was 10 mg of lithium aspartate taken once daily, a tiny fraction of the 900 to 1,800 mg daily doses used in psychiatric treatment.20PubMed Central. A Survey Exploring People’s Experiences With Lithium Bought as a Supplement
At these low doses, the risk of acute toxicity is extremely small. The concern is not that someone will accidentally poison themselves with lithium supplements but rather that the unregulated nature of supplements means doses, formulations, and quality vary widely. Someone who decides to scale up their own supplement dose based on internet advice, or who combines supplements with a prescription they did not disclose to their doctor, could potentially reach dangerous territory. The key distinction is elemental lithium content: a 300 mg lithium carbonate tablet contains about 56 mg of elemental lithium, while a typical supplement capsule might deliver 5 mg of elemental lithium. The pharmacological reality of these products belongs to entirely different risk categories.
Lithium Chloride as a Salt Substitute
Before lithium’s psychiatric uses were well established, lithium chloride was marketed in the United States as a table-salt replacement for people on sodium-restricted diets, mainly those with heart or kidney disease. In 1949, JAMA published a report describing seven cases of lithium intoxication from one such product, with two of those cases contributing to the patients’ deaths.21JAMA. LITHIUM POISONING FROM THE USE OF SALT SUBSTITUTES The patients most affected were exactly the people who should have been most cautious: those with existing heart and kidney disease, whose compromised organs could not clear the lithium effectively. These patients were shaking the salt substitute liberally onto their food, accumulating lithium with every meal, with no monitoring whatsoever.
The 1949 salt-substitute disasters were instrumental in shaping how carefully lithium is monitored today. They demonstrated, before lithium was even introduced as a psychiatric medication, that this element has an unusually small margin between a harmless amount and a harmful one. The requirement for regular blood level monitoring that accompanies every lithium prescription traces directly back to lessons learned from people who simply wanted their food to taste better.